Literature DB >> 12031076

Serological screening for cysticercosis in mentally altered individuals.

Fernando Sanzón1, Ana M Osorio, José P Morales, Rodrigo Isaza, Edgar Cardona, Luis C Moncayo, Guido E Villota, Olga T Zapata, Carlos A Palacio, María P Arbeláez, Blanca I Restrepo.   

Abstract

The parasitic infection neurocysticercosis may give rise to a variety of psychiatric manifestations that resemble, but are different from, primary psychiatric disorders. The aim of this study was to determine if among individuals from a neurocysticercosis-endemic area of Colombia who apparently had a psychiatric manifestation with associated neurological finding ('cases'), some could have been infected with Taenia solium cysticerci. This case-control study was done in individuals hospitalized in two mental institutions. The control-1 individuals were those classified with primary psychiatric disease, and the control-2 group consisted of healthy, non-hospitalized individuals. A serological test for cysticercosis was positive in 5/96 (5.1%) cases, 4/153 (2.6%) psychiatric controls, and 5/246 (2%) healthy controls. The data analysis indicated a weak association between the cases and a positive serology for neurocysticercosis (odds ratio > 2; P > 0.05). The lower education level of the cases influenced this association.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031076     DOI: 10.1046/j.1365-3156.2002.00886.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  2 in total

1.  Neurocysticercosis and population movements: analysis of 23 imported cases in Spain.

Authors:  C Roca; J Gascón; B Font; T Pujol; M E Valls; M Corachán
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-29       Impact factor: 3.267

Review 2.  Epidemiology, clinical manifestations and diagnosis of zoonotic cestode infections: an update.

Authors:  W Raether; H Hänel
Journal:  Parasitol Res       Date:  2003-09-16       Impact factor: 2.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.